PD-1 inhibitors - Globe Thesis

Keyword [PD-1 inhibitors] Result: 1 - 20 \| Page: 1 of 2
1.	The Research Of Changes Of Some Immune Cells And Immune Checkpoints In Tumor Immune Microenvironment Before And After Treatment With PD-1 Inhibitors
2.	Research Of Novel Skin Toxicities Of Anti-PD-1 Treatment And Mechanism Of Resistance To Anti-HER2 Treatment For Advanced Solid Tumors
3.	The Incidence And Risk Factors Of Pneumonitis In Patients Treated With Immune Checkpoint Inhibitors
4.	Treatment Of Advanced Digestive Tract Tumor With PD-1 Inhibitor In 2 Cases And Literature Review
5.	The Efficacy And Safety Of PD-1 Inhibitors Alone Or In Combination With Radiotherapy In Malignant Melanoma: A Secondary Analysis
6.	Establishment And Validation Of Prognostic Nomogram For Advanced Non-small Cell Lung Cancer Patients Treated With PD-1 Inhibitors
7.	Study On The Effect Of 3-MA And PD-1 Inhibitors In The Synergistic Treatment Of Colon Cancer With Different Mismatch
8.	Analysis Of Prognostic Value Of NLR And PLR In Patients With Liver Cancer Treated With PD-1 Inhibitors
9.	Study On TCM Syndrome Types Of 53 Patients With Advanced Non-small Cell Lung Cancer Before And After Treatment With PD-1 Inhibitor
10.	1.Multi-omics Analysis Reveals The Molecular Evolutionary Mechanism Of Esophageal Squamous Cell Carcinoma And Dysplasia 2.Effect Of PD-1 Inhibitor On The Immune Status Of Peripheral Blood In Cancer Patients
11.	The Role And Evaluation Of Anlotinib And PD-1 Inhibitors In Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Based On Interventional Therapy
12.	Analysis Of Influencing Factors Of PD-1 Inhibitor-related Adverse Thyroid Reactions
13.	Study On The Efficacy And Prognostic Predictive Value Of Systemic Immune-inflammation Index And Prognostic Nutrition Index In Patients With Advanced Non-small Cell Lung Cancer Treated With PD-1 Inhibitors
14.	Predictive Factors For Durable Clinical Benefit Of PD-1 Inhibitors In Patients With Advanced Non-small Cell Lung Cancer
15.	PD-1 Inhibitors In Combination With Other Drugs For Advanced Non-small Cell Lung Cancer
16.	Significance Of Soluble PD-L1,CTLA-4 And B7-H3 In Peripheral Blood In Healthy Patients And Patients With Lung Cancer Treated With PD-1 Inhibitors
17.	Prognostic Value Of Peripheral Blood Platelets And Leukocytes In Patients With Advanced Non-small Cell Lung Cancer Treated With PD-1 Inhibitors
18.	A Meta-analysis Of The Efficacy And Safety Of PD-1 Inhibitors In Treatment Of Relapsed/refractory Hodgkin Lymphoma
19.	Evaluation Of The Effect Of PD-1 Inhibitors On Cardiac Function In Tumor Patients By Two-dimensional Speckle Tracking Imaging Combined With Real-time Three-dimensional Echocardiography
20.	Low-Dose Carboplatin Reprograms Tumor Immune Microenvironment Through STING Signaling Pathway And Synergizes With PD-1 Inhibitors In Lung Cancer
<<First <Prev Next> Last>> Jump to